Continue with FacebookLooking to list your PhD opportunities? Log in here.
immunotherapy PhD Projects, Programmes & Scholarships
We have 12 immunotherapy PhD Projects, Programmes & Scholarships
PhD saved successfully
Cancer: Complex 3D modelling of the tumour microenvironment for immunotherapy combination screening
Cancer immunotherapy holds significant promise for the treatment of a range of cancers. Read more
Immunotherapy: Killing Cancer using Dead Virus
It is now accepted that our immune systems can hold the key to treating otherwise incurable cancers. So-called “immunotherapy” is an increasingly common method of treating tumours, leading to impressive increases in patient responses. . Read more
Developing molecularly imprinted polymeric nanocarriers for targeted cancer immunotherapy
This exciting interdisciplinary research will marry expertise in molecular imprinted polymers, nanomedicine and cancer immunotherapy. Read more
Immunotherapy: Manipulating T cell metabolism to improve anti-tumour immunity
The induction of immune responses to tumours can provide long-lasting protection from cancer. In this regard, T cells can suppress tumour growth by directly killing cancer cells and by producing inflammatory cytokines. Read more
Develop single-cell biomechanical nanotools for novel cardiovascular mechanobiology and cancer immunotherapy
In view of the high complexity and dynamics of protein complexes that perform important physiological functions, it is difficult to visualise and characterise their kinetic and signaling processes on single living cells using traditional biochemical and biophysical techniques. Read more
Last chance to apply
Investigating the immune-stimulating effects and therapeutic potential of conjugates for antibody-mediated delivery of nucleic acid adjuvants to the tumour microenvironment
Clinical advances in tumour immunotherapy based on immune checkpoint blockade have proven that the ability of the immune system to eradicate tumours can be harnessed in the clinical setting and have reignited an interest in immunotherapies. Read more
Last chance to apply
Fully funded 3.5 year PhD Studentship: Functional interplay between PARP1 inhibition and microenvironment in glioblastoma
Applications from prospective students are invited for this fully funded* 3.5 year PhD studentship to start in October 2023, under the joint supervision of. Read more
Direct identification of the antigenic triggers for immunotoxic T lymphocytes
Applications are invited for a 4 year PhD studentship to join the Thaventhiran lab at the MRC Toxicology Unit, University of Cambridge. Read more
CAR T cell Immune Therapy for Cancer: Mechanisms and Dynamics explored by Microscopy
Applications are invited for a research studentship leading to the award of a PhD degree. The project will be based in Prof. Dan Davis’s laboratory, based in the South Kensington campus of Imperial College London, funded by a collaboration with the pharmaceutical company Bristol Myers Squibb, based in the USA. Read more
Last chance to apply
Modelling cargo loaded macrophage trafficking across liver endothelium: a new approach to drug delivery in liver cancer
Cases of primary liver cancer, also known as hepatocellular cancer (HCC) are rising rapidly in the UK and new therapies are urgently needed. Read more
Cancer: Understanding the immunosuppressive role of fibroblast and macrophages in Breast cancer
Oncolytic viruses (OVs) preferentially infect and kill cancer cells, and their clinical efficacy has been demonstrated against a number of different cancers. The most clinically advanced OV is a genetically engineered herpes simplex virus (T-VEC) which expresses GMCSF to aid the development of anti-tumour immune responses; T-VEC is approved for the treatment of metastatic melanoma. Read more
Preclinical validation of NUDT22 as target in lung cancer
We previously identified NUDT22 as an UDP-glucose hydrolase and an important new player in nucleotide and energy metabolism. Read more
- 1